VOYA Investment Management’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.6M Buy
664,146
+530,932
+399% +$19.6M 0.03% 414
2025
Q4
$4.73M Buy
133,214
+71,591
+116% +$2.01M ﹤0.01% 889
2025
Q3
$885K Buy
61,623
+32,279
+110% +$382K ﹤0.01% 1526
2025
Q2
$211K Buy
29,344
+3,916
+15% +$21.7K ﹤0.01% 2307
2025
Q1
$152K Sell
25,428
-2,471
-9% -$19.4K ﹤0.01% 2335
2024
Q4
$218K Sell
27,899
-2,333
-8% -$23.3K ﹤0.01% 2358
2024
Q3
$327K Sell
30,232
-591
-2% -$5.75K ﹤0.01% 2225
2024
Q2
$260K Buy
30,823
+3,503
+13% +$26.6K ﹤0.01% 2327
2024
Q1
$184K Sell
27,320
-5,476
-17% -$33.9K ﹤0.01% 2484
2023
Q4
$193K Buy
32,796
+447
+1% +$3.42K ﹤0.01% 2589
2023
Q3
$315K Buy
32,349
+4,960
+18% +$58.8K ﹤0.01% 2280
2023
Q2
$324K Buy
27,389
+2,938
+12% +$33.7K ﹤0.01% 2320
2023
Q1
$264K Hold
24,451
﹤0.01% 2391
2022
Q4
$283K Hold
24,451
﹤0.01% 2370
2022
Q3
$365K Buy
24,451
+7,623
+45% +$104K ﹤0.01% 2231
2022
Q2
$152K Buy
16,828
+2,016
+14% +$13.8K ﹤0.01% 2501
2022
Q1
$111K Hold
14,812
﹤0.01% 2498
2021
Q4
$127K Sell
14,812
-144
-1% -$1.25K ﹤0.01% 2626
2021
Q3
$126K Hold
14,956
﹤0.01% 2689
2021
Q2
$121K Buy
+14,956
New +$126K ﹤0.01% 2739
2019
Q2
Sell
-2,778
Closed -$49K 2588
2019
Q1
$49K Hold
2,778
﹤0.01% 2509
2018
Q4
$49K Buy
+2,778
New +$82.2K ﹤0.01% 2488

Other funds holding COGT

VOYA Investment Management's COGT Position: Q1 2026 in Review

VOYA Investment Management increased its Cogent Biosciences (COGT) stake by 399% in Q1 2026, buying an estimated $19.6M and bringing the position to 664,146 shares worth $25.6M. The position accounts for 0.03% of the portfolio, ranked #414.

VOYA Investment Management first reported a position in COGT in Q4 2018 and has held it in 22 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • VOYA Investment Management held 664,146 shares of Cogent Biosciences worth $25.6M as of Q1 2026.
  • VOYA Investment Management bought 530,932 Cogent Biosciences shares in Q1 2026, an estimated $19.6M.
  • Cogent Biosciences made up 0.03% of VOYA Investment Management's portfolio in Q1 2026, its #414 holding.
  • VOYA Investment Management first reported a position in Cogent Biosciences in Q4 2018 and has held it in 22 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.